Logo image of FIVE

FIVE BELOW (FIVE) Stock Fundamental Analysis

NASDAQ:FIVE - Nasdaq - US33829M1018 - Common Stock - Currency: USD

126.47  +4.64 (+3.81%)

After market: 126.47 0 (0%)

Fundamental Rating

5

FIVE gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 121 industry peers in the Specialty Retail industry. FIVE is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. FIVE is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

FIVE had positive earnings in the past year.
In the past year FIVE had a positive cash flow from operations.
Each year in the past 5 years FIVE has been profitable.
Each year in the past 5 years FIVE had a positive operating cash flow.
FIVE Yearly Net Income VS EBIT VS OCF VS FCFFIVE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M

1.2 Ratios

FIVE's Return On Assets of 5.91% is fine compared to the rest of the industry. FIVE outperforms 72.73% of its industry peers.
FIVE has a better Return On Equity (14.17%) than 71.07% of its industry peers.
Looking at the Return On Invested Capital, with a value of 7.07%, FIVE is in the better half of the industry, outperforming 65.29% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for FIVE is below the industry average of 13.13%.
Industry RankSector Rank
ROA 5.91%
ROE 14.17%
ROIC 7.07%
ROA(3y)7.16%
ROA(5y)7.3%
ROE(3y)17.41%
ROE(5y)18.22%
ROIC(3y)8.48%
ROIC(5y)9.59%
FIVE Yearly ROA, ROE, ROICFIVE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

FIVE has a better Profit Margin (6.52%) than 81.82% of its industry peers.
FIVE's Profit Margin has declined in the last couple of years.
The Operating Margin of FIVE (8.39%) is better than 79.34% of its industry peers.
FIVE's Operating Margin has declined in the last couple of years.
The Gross Margin of FIVE (35.02%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of FIVE has remained more or less at the same level.
Industry RankSector Rank
OM 8.39%
PM (TTM) 6.52%
GM 35.02%
OM growth 3Y-21.23%
OM growth 5Y-6.62%
PM growth 3Y-12.57%
PM growth 5Y-7.15%
GM growth 3Y-1.19%
GM growth 5Y-0.89%
FIVE Yearly Profit, Operating, Gross MarginsFIVE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

7

2. Health

2.1 Basic Checks

FIVE has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, FIVE has less shares outstanding
The number of shares outstanding for FIVE has been reduced compared to 5 years ago.
FIVE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
FIVE Yearly Shares OutstandingFIVE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
FIVE Yearly Total Debt VS Total AssetsFIVE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.2 Solvency

FIVE has an Altman-Z score of 3.41. This indicates that FIVE is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of FIVE (3.41) is better than 76.86% of its industry peers.
FIVE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3.41
ROIC/WACC0.74
WACC9.51%
FIVE Yearly LT Debt VS Equity VS FCFFIVE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B

2.3 Liquidity

FIVE has a Current Ratio of 1.71. This is a normal value and indicates that FIVE is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.71, FIVE is in the better half of the industry, outperforming 72.73% of the companies in the same industry.
FIVE has a Quick Ratio of 1.71. This is a bad value and indicates that FIVE is not financially healthy enough and could expect problems in meeting its short term obligations.
With a decent Quick ratio value of 0.89, FIVE is doing good in the industry, outperforming 72.73% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.71
Quick Ratio 0.89
FIVE Yearly Current Assets VS Current LiabilitesFIVE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

6

3. Growth

3.1 Past

FIVE shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -0.93%.
Measured over the past years, FIVE shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.07% on average per year.
The Revenue has grown by 10.70% in the past year. This is quite good.
The Revenue has been growing by 15.99% on average over the past years. This is quite good.
EPS 1Y (TTM)-0.93%
EPS 3Y0.6%
EPS 5Y10.07%
EPS Q2Q%43.33%
Revenue 1Y (TTM)10.7%
Revenue growth 3Y10.82%
Revenue growth 5Y15.99%
Sales Q2Q%19.54%

3.2 Future

The Earnings Per Share is expected to grow by 30.76% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 16.48% on average over the next years. This is quite good.
EPS Next Y-6.13%
EPS Next 2Y0.33%
EPS Next 3Y4.76%
EPS Next 5Y30.76%
Revenue Next Year12.5%
Revenue Next 2Y10.94%
Revenue Next 3Y10.71%
Revenue Next 5Y16.48%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
FIVE Yearly Revenue VS EstimatesFIVE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2B 4B 6B 8B
FIVE Yearly EPS VS EstimatesFIVE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 5 10 15 20

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 23.86 indicates a rather expensive valuation of FIVE.
Based on the Price/Earnings ratio, FIVE is valued a bit cheaper than 61.98% of the companies in the same industry.
FIVE is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.57, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 24.93, which indicates a rather expensive current valuation of FIVE.
FIVE's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of FIVE to the average of the S&P500 Index (22.41), we can say FIVE is valued inline with the index average.
Industry RankSector Rank
PE 23.86
Fwd PE 24.93
FIVE Price Earnings VS Forward Price EarningsFIVE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

FIVE's Enterprise Value to EBITDA ratio is in line with the industry average.
FIVE's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. FIVE is cheaper than 62.81% of the companies in the same industry.
Industry RankSector Rank
P/FCF 26.32
EV/EBITDA 11.42
FIVE Per share dataFIVE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The decent profitability rating of FIVE may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)2.37
EPS Next 2Y0.33%
EPS Next 3Y4.76%

0

5. Dividend

5.1 Amount

FIVE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

FIVE BELOW

NASDAQ:FIVE (6/16/2025, 8:00:00 PM)

After market: 126.47 0 (0%)

126.47

+4.64 (+3.81%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)06-04 2025-06-04/amc
Earnings (Next)08-26 2025-08-26
Inst Owners104.17%
Inst Owner Change0.02%
Ins Owners0.95%
Ins Owner Change6.78%
Market Cap6.96B
Analysts72.14
Price Target110.5 (-12.63%)
Short Float %9.03%
Short Ratio1.82
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.27%
Min EPS beat(2)1.27%
Max EPS beat(2)3.28%
EPS beat(4)3
Avg EPS beat(4)36.99%
Min EPS beat(4)-2.24%
Max EPS beat(4)145.65%
EPS beat(8)4
Avg EPS beat(8)18.01%
EPS beat(12)6
Avg EPS beat(12)19.93%
EPS beat(16)8
Avg EPS beat(16)17.62%
Revenue beat(2)0
Avg Revenue beat(2)-1.35%
Min Revenue beat(2)-1.55%
Max Revenue beat(2)-1.15%
Revenue beat(4)1
Avg Revenue beat(4)-0.03%
Min Revenue beat(4)-1.55%
Max Revenue beat(4)3.58%
Revenue beat(8)1
Avg Revenue beat(8)-1.27%
Revenue beat(12)2
Avg Revenue beat(12)-1.08%
Revenue beat(16)3
Avg Revenue beat(16)-1.04%
PT rev (1m)8.51%
PT rev (3m)-7.62%
EPS NQ rev (1m)24.01%
EPS NQ rev (3m)-6.4%
EPS NY rev (1m)0%
EPS NY rev (3m)-9.92%
Revenue NQ rev (1m)5.43%
Revenue NQ rev (3m)6.32%
Revenue NY rev (1m)0.25%
Revenue NY rev (3m)2.02%
Valuation
Industry RankSector Rank
PE 23.86
Fwd PE 24.93
P/S 1.73
P/FCF 26.32
P/OCF 12.97
P/B 3.75
P/tB 3.75
EV/EBITDA 11.42
EPS(TTM)5.3
EY4.19%
EPS(NY)5.07
Fwd EY4.01%
FCF(TTM)4.8
FCFY3.8%
OCF(TTM)9.75
OCFY7.71%
SpS73.29
BVpS33.75
TBVpS33.75
PEG (NY)N/A
PEG (5Y)2.37
Profitability
Industry RankSector Rank
ROA 5.91%
ROE 14.17%
ROCE 9.43%
ROIC 7.07%
ROICexc 8.55%
ROICexgc 8.55%
OM 8.39%
PM (TTM) 6.52%
GM 35.02%
FCFM 6.56%
ROA(3y)7.16%
ROA(5y)7.3%
ROE(3y)17.41%
ROE(5y)18.22%
ROIC(3y)8.48%
ROIC(5y)9.59%
ROICexc(3y)9.94%
ROICexc(5y)11.39%
ROICexgc(3y)9.94%
ROICexgc(5y)11.39%
ROCE(3y)11.31%
ROCE(5y)12.79%
ROICexcg growth 3Y-24.82%
ROICexcg growth 5Y-8.07%
ROICexc growth 3Y-24.82%
ROICexc growth 5Y-8.07%
OM growth 3Y-21.23%
OM growth 5Y-6.62%
PM growth 3Y-12.57%
PM growth 5Y-7.15%
GM growth 3Y-1.19%
GM growth 5Y-0.89%
F-Score6
Asset Turnover0.91
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 154.01%
Cap/Sales 6.75%
Interest Coverage 250
Cash Conversion 104.18%
Profit Quality 100.47%
Current Ratio 1.71
Quick Ratio 0.89
Altman-Z 3.41
F-Score6
WACC9.51%
ROIC/WACC0.74
Cap/Depr(3y)229.46%
Cap/Depr(5y)263.43%
Cap/Sales(3y)8.65%
Cap/Sales(5y)9.26%
Profit Quality(3y)40.25%
Profit Quality(5y)53.87%
High Growth Momentum
Growth
EPS 1Y (TTM)-0.93%
EPS 3Y0.6%
EPS 5Y10.07%
EPS Q2Q%43.33%
EPS Next Y-6.13%
EPS Next 2Y0.33%
EPS Next 3Y4.76%
EPS Next 5Y30.76%
Revenue 1Y (TTM)10.7%
Revenue growth 3Y10.82%
Revenue growth 5Y15.99%
Sales Q2Q%19.54%
Revenue Next Year12.5%
Revenue Next 2Y10.94%
Revenue Next 3Y10.71%
Revenue Next 5Y16.48%
EBIT growth 1Y-10.76%
EBIT growth 3Y-12.71%
EBIT growth 5Y8.3%
EBIT Next Year49.6%
EBIT Next 3Y22.15%
EBIT Next 5Y30.4%
FCF growth 1Y122.11%
FCF growth 3Y39.02%
FCF growth 5YN/A
OCF growth 1Y49.92%
OCF growth 3Y9.51%
OCF growth 5Y18.16%